Dale Q Rice Investment Management Ltd Trims Stake in Lam Research Corporation $LRCX

Key Points

• Dale Q Rice Investment Management Ltd reduced its stake in Lam Research Corporation by 50% in the second quarter, leaving them with 6,490 shares valued at approximately $651,000.
• Lam Research reported a quarterly EPS of $1.33, exceeding estimates, while revenue reached $5.17 billion, a 33.6% increase year-over-year.
• The company recently increased its quarterly dividend to $0.26, up from $0.23, reflecting a commitment to return value to shareholders.

Dale Q Rice Investment Management Ltd reduced its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 50.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 6,490 shares of the semiconductor company's stock after selling 6,490 shares during the period. Lam Research accounts for about 0.5% of Dale Q Rice Investment Management Ltd's holdings, making the stock its 29th biggest holding. Dale Q Rice Investment Management Ltd's holdings in Lam Research were worth $651,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. REAP Financial Group LLC purchased a new stake in shares of Lam Research in the 2nd quarter valued at about $31,000. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Lam Research during the 1st quarter worth approximately $26,000. Hilltop National Bank purchased a new stake in Lam Research in the 2nd quarter valued at approximately $38,000. Bruce G. Allen Investments LLC lifted its stake in Lam Research by 207.3% in the 2nd quarter. Bruce G. Allen Investments LLC now owns 421 shares of the semiconductor company's stock valued at $41,000 after buying an additional 284 shares in the last quarter. Finally, 1 North Wealth Services LLC purchased a new stake in Lam Research in the 1st quarter valued at approximately $36,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Stock Down 0.6%

Shares of NASDAQ LRCX opened at $141.51 on Friday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $153.70. The company has a market cap of $178.45 billion, a P/E ratio of 34.02, a P/E/G ratio of 1.73 and a beta of 1.84. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. The stock has a fifty day moving average price of $119.06 and a 200 day moving average price of $96.78.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.12. The firm had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm's quarterly revenue was up 33.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. This is a positive change from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date was Wednesday, September 24th. Lam Research's payout ratio is 25.00%.

Insider Buying and Selling

In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.31% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on LRCX. TD Cowen raised their price objective on Lam Research from $125.00 to $145.00 and gave the stock a "buy" rating in a report on Monday, October 13th. Deutsche Bank Aktiengesellschaft upgraded Lam Research from a "hold" rating to a "buy" rating and raised their price objective for the stock from $100.00 to $150.00 in a report on Monday, September 29th. Needham & Company LLC increased their target price on Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Wells Fargo & Company increased their target price on Lam Research from $98.00 to $135.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 2nd. Finally, HSBC set a $127.00 target price on Lam Research and gave the stock a "hold" rating in a research report on Tuesday, September 30th. Twenty-three research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $125.08.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.